Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2019-08-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-019-05411-9PMID 31446535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk

  2019cited by this paper
• Combined tumor sequencing and case/control analyses of RAD51C in breast cancer.

  2019cited by this paper
• Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing

  2018cited by this paper
• Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

  2018cited by this paper
• A high frequency of PALB2 mutations in Jamaican patients with breast cancer

  2017cited by this paper
• Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

  2016cited by this paper
• Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry

  2016cited by this paper
• Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland

  2015cited by this paper
• The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective

  2015cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

  2015cited by this paper
• RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families

  2014cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia

  2014cited by this paper
• Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe

  2014cited by this paper
• Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer

  2014cited by this paper
• Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan

  2014cited by this paper
• Breast-cancer risk in families with mutations in PALB2.

  2014cited by this paper
• BREAST CANCER-ASSOCIATED MISSENSE MUTANTS OF THE PALB2 WD40 DOMAIN, WHICH DIRECTLY BINDS RAD51C, RAD51 AND BRCA2, DISRUPT DNA REPAIR

  2013cited by this paper
• Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation.

  2013cited by this paper
• Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.

  2012cited by this paper
• Novel germline PALB2 truncating mutations in African American breast cancer patients

  2012cited by this paper
• Mutation screening of RAD51C in high-risk breast and ovarian cancer families

  2012cited by this paper
• Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families

  2011cited by this paper
• Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

  2011cited by this paper
• RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families

  2011cited by this paper
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• A PALB2 mutation associated with high risk of breast cancer

  2010cited by this paper
• Estudio de factores genØticos para cÆncer de mama en Colombia

  2009cited by this paper
• Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

  2007cited by this paper
• PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

  2007cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil

  2007cited by this paper
• A recurrent mutation in PALB2 in Finnish cancer families

  2007cited by this paper

• Prevalencia de Dos Variantes en BRCA2 en Mujeres con Cáncer de Mama del Hospital Día Oncológico, Encarnación, Paraguay, 2023: Estudio Piloto

  2025cites this paper
• Germline Genetic Variants in Cancer Predisposition Genes in Patients From Latin America and the Caribbean.

  2025cites this paper
• Variantes patogénicas en BRCA2 en mujeres con cáncer de mama del Hospital Día Oncológico de Encarnación- Paraguay, período 2023

  2025cites this paper
• Prevalence of Two Variants of BRCA2 in Women with Breast Cancer of the Hospital Día Oncológico, Encarnación, Paraguay, 2023: a Pilot Study

  2025cites this paper
• Clinical Management in BRCA Carriers with Early Breast Cancer

  2025cites this paper
• Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients

  2024influential citation
• Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population

  2024cites this paper
• PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina

  2022cites this paper
• Genetic predisposition to male breast cancer in Poland

  2021cites this paper
• Mutaciones genéticas asociadas a cáncer de mama hereditario en mujeres nicaragüenses

  2021cites this paper